BD Publishes 2022 Cybersecurity Annual Report

Rhea-AI Summary

BD (NYSE: BDX) has released its 2022 Cybersecurity Annual Report, emphasizing the company's commitment to enhancing cybersecurity measures in healthcare. The report focuses on transparency and collaboration, detailing efforts to protect patient safety and privacy amidst rising cyber threats like ransomware and phishing. Key highlights include BD's coordinated vulnerability disclosure processes, collaborations with cybersecurity working groups, and proactive measures against emerging risks. The report aims to empower customers by providing essential information on managing cyber risks effectively.

Positive

• Launch of the 2022 Cybersecurity Annual Report demonstrates BD's commitment to transparency.
• Detailed vulnerability disclosure processes empower customers to manage cyber risks.
• Collaborative efforts with cybersecurity groups enhance overall industry security.
• Proactive measures outlined in the report address rising cyber threats effectively.

Negative

• None.

Highlights Critical Importance of Transparency and Collaboration

FRANKLIN LAKES, N.J., Jan. 25, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released its third annual cybersecurity report to update stakeholders about the company's ongoing efforts to advance cybersecurity maturity, protect against cyberattacks and empower customers with information about cyber risks and vulnerabilities.

Through the BD 2022 Cybersecurity Annual Report, the company is increasing awareness of health care cybersecurity challenges and the company's commitment to transparency and collaboration.

"In health care, cybersecurity is about protecting patient safety and privacy, while also securing systems and data," said Rob Suárez, chief information security officer of BD. "Patients receive medical care at some of the most critical and vulnerable moments in their lives. They trust the safeguards put in place to protect them. Upholding strong cybersecurity measures and continuing to advance cybersecurity is part of honoring that trust."

In the context of recent cybersecurity trends and developments, the report discusses:

• Transparency and communication – BD strives to help customers manage risk properly through awareness and guidance. The BD 2022 Cybersecurity Annual Report outlines the company's mature coordinated vulnerability disclosure processes and how customers can access product security documentation, including certifications and attestations from Underwriters Laboratories Cybersecurity Assurance Program (UL CAP), System and Organization Controls (SOC2) and the International Standards Organization (ISO/IEC 27001:2022).
• Collaborative efforts to advance cybersecurity – Strengthening cybersecurity across the health care industry requires collaboration. The report highlights the work of multiple cybersecurity working groups and outlines the company's contributions to advancing secure cybersecurity practices, including ethical hacking exercises, cybersecurity scenario trainings and preparing for greater software-bill-of-materials (SBOM) visibility.
• The state of health care cybersecurity – Ransomware, phishing and software supply chain attacks reinforce the need for strong proactive and preventive measures. The report details how the company strives to protect its products, manufacturing operational technology and enterprise IT from emerging risks and threats.

For more information about the company's approach to cybersecurity, download the BD 2022 Cybersecurity Annual Report.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.

Contacts:
Media:	Investors:
Jennifer Wolf	Francesca DeMartino
Associate Director, Cybersecurity Communications	SVP, Head of Investor Relations
201-258-0540	201.847.5743
jennifer.wolf@bd.com	francesca.demartino@bd.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-publishes-2022-cybersecurity-annual-report-301730093.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

What are the key highlights from BD's 2022 Cybersecurity Annual Report?

Key highlights include a focus on transparency, collaborative efforts to enhance cybersecurity, and proactive measures against emerging threats like ransomware and phishing.

How does BD aim to protect patient safety in the context of cybersecurity?

BD focuses on protecting patient safety by enhancing cybersecurity measures and providing customers with information about risks and vulnerabilities.

What measures does BD take to manage cybersecurity risks?

BD implements coordinated vulnerability disclosure processes and collaborates with cybersecurity working groups to strengthen security across the healthcare sector.

When was BD's 2022 Cybersecurity Annual Report released?

BD published its 2022 Cybersecurity Annual Report on January 25, 2023.